A well-known Coronavirus expert at the Wuhan Institute of Virology said that bats in China and countries in South Asia were carrying other Coronaviruses that could be transmitted to humans.

According to a report by the British newspaper, The Independent.

At a time the World Health Organization warned that popularizing vaccines does not mean the disappearance of Covid-19.

Dr. Shi Chengli, known as the Bat Woman (Bat Woman) for her ability to track viruses from SARS to COVID-19, made the remarks at a webinar Thursday during a joint session of the National Academy of Medicine and the Veterinary Academy of France.

The "Bat Woman" said that some viruses were similar to the emerging corona virus - its scientific name is Sars-CoV-2.

According to the World Health Organization, corona viruses are a widespread family of viruses that are known to cause diseases ranging from common colds to more severe diseases, such as the Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS).

Coronaviruses are zoonotic, meaning that they are transmitted between animals and humans.

Detailed investigations have concluded that the SARS-CoV virus has passed from civet cats to humans.

"We should not only look for them in China, but also in the countries of South Asia," said Xi.

Research by the "Batwoman" team found other coronaviruses in southern China.

"We believe that these viruses have a high risk of being transmitted between species to humans," said Dr. Shi.

It is possible that the "SARS-Cove 2" virus may have originated among bats, but Dr. Shi, along with other scientists, believe that the virus passed from an intermediate animal to humans.

There is also a question mark over the length of time that the "SARS Cove 2" virus has spent, as Dr. Shi told the committee that it could have been in humans or animals "for a very long time" before its discovery.

She stated that if the intermediate carrier of the virus is the scaly anteater, as some studies have indicated, then there is a possibility that the virus originated in a bat outside China.

The pangolin is usually smuggled into China from other parts of Asia and Africa.

The health organization warns

On Friday, World Health said that popularizing vaccines to combat the Covid-19 epidemic would not be sufficient by itself to eliminate the deadly virus.

The organization warned of a feeling of satisfaction and of "the misconception that the availability of vaccines soon means the end of the crisis."

"Vaccines do not mean zero Covid," said Mike Ryan, director of the WHO's emergency health cases program, in a press conference via the Internet.

He explained that it alone "will not fulfill the mission," adding that "the vaccine will not be available to everyone at the beginning of next year."

Last Wednesday, Britain became the first Western country to license a general use of a vaccine, which increased pressure on other countries to quickly catch up with it.

WHO Director-General Tedros Adhanom Ghebreyesus said that the progress on vaccines "is giving us all a push forward. Now we can start to see the light at the end of the tunnel."

However, the WHO is concerned about the widespread perception that the epidemic is over.

Infection height

"The fact is that at present, many places are witnessing a drastic increase in the transmission of the virus, which poses tremendous pressure on hospitals, intensive care units and health workers," Ghebreyesus added.

The number of Coronavirus infections exceeded 65 million Friday.

It has also led to the death of 1.5 million people since its appearance in China last December, according to official sources relied on by the French Press Agency.

And Ghebreyesus returned by saying, "The decisions taken by leaders and citizens will both determine the course of the virus in the short term, and when this epidemic will end completely."

For her part, Maria Van Kerkhove, head of the technical team on Covid-19 at the WHO, said that these decisions "could mean life or death for us, and for our family."

According to WHO's review of the candidate vaccines, clinical trials are currently underway on 51 vaccines, 13 of which have reached the final stage of large-scale trials.

Another 163 candidate vaccines are being developed in laboratories and are expected to eventually undergo clinical trials.